Maura L Gillison

14PUBLICATIONS
197CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Mar 19, 2026
FOXM1-Specific TCR-Engineered T Cells Target Non-Small Cell Lung Cancer.

Emily Bontekoe, Minying Zhang, Peixin Jiang

|Mar 06, 2026
The KRAS-Variant and Cetuximab in HPV-Positive Oropharyngeal Cancer: Results from the NRG/RTOG 1016 Trial.

Joanne B Weidhaas, Jonathan Harris, Maura L Gillison

|Jun 13, 2025
LiGeR-HN phase III trials of petosemtamab + pembrolizumab and petosemtamab monotherapy in recurrent or metastatic HNSCC.

Jean-Pascal Machiels, Jérôme Fayette, Robert Haddad

|May 13, 2025
Human Papillomavirus Integration Induces Oncogenic Host Gene Fusions in Oropharyngeal Cancers.

Nusrat Khan, Keiko Akagi, Shiming Jiang

|Apr 18, 2025
Depletion of Effector Regulatory T Cells Associates with Major Response to Induction Dual Immune Checkpoint Blockade.

Xianli Jiang, Nils-Petter Rudqvist, Bo Jiang

|Jan 28, 2025
Time Dependency for Human Papillomavirus Circulating Tumor DNA Detection after Chemoradiation as a Prognostic Biomarker for Localized Anal Cancer.

Van K Morris, Weihong Xiao, Kangyu Lin

Pageof 3

Frequent Collaborators

6 joint publications

Weihong Xiao

4 joint publications

J Jack Lee

3 joint publications

Joe Dan Dunn

3 joint publications

Bo Jiang